|
|
|
Insider
Information: |
Baird William D Iii |
Relationship: |
|
City: |
Cranbury |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
449,004 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,268,601 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
449,004 |
|
|
Total
Value |
$1,268,601 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
4
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
Percentage
Gain/Loss : |
0.0%
|
-153.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amicus Therapeutics Inc |
FOLD |
Chief Financial Officer |
2018-10-15 |
117,622 |
2014-04-10 |
0 |
Premium* |
|
Bluebird Bio, Inc. |
BLUE |
Chief Financial Officer |
2021-11-11 |
22,797 |
2019-03-01 |
0 |
Premium* |
|
2seventy Bio, Inc. |
TSVT |
|
2024-04-01 |
308,585 |
2022-01-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2014-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2014-09-29 |
4 |
AB |
$6.09 |
$154,111 |
D/D |
25,311 |
125,311 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2014-09-29 |
4 |
AS |
$6.09 |
$154,111 |
D/D |
(25,311) |
100,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2014-10-03 |
4 |
AB |
$7.00 |
$70,000 |
D/D |
10,000 |
110,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2014-10-03 |
4 |
AS |
$7.00 |
$70,000 |
D/D |
(10,000) |
100,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2014-11-25 |
4 |
AB |
$8.00 |
$80,000 |
D/D |
10,000 |
110,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2014-11-25 |
4 |
AS |
$8.00 |
$80,000 |
D/D |
(10,000) |
100,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2015-03-20 |
4 |
AS |
$11.51 |
$175,294 |
D/D |
(15,235) |
100,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2015-03-20 |
4 |
OE |
$11.51 |
$175,294 |
D/D |
15,235 |
115,235 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2015-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2015-05-08 |
4 |
D |
$10.80 |
$201,150 |
D/D |
(18,625) |
31,375 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2015-05-11 |
4 |
AS |
$10.84 |
$268,810 |
D/D |
(24,800) |
6,575 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2015-06-19 |
4 |
OE |
$13.26 |
$202,057 |
D/D |
15,235 |
71,810 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2015-06-19 |
4 |
AS |
$13.26 |
$202,057 |
D/D |
(15,235) |
56,575 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2015-09-21 |
4 |
AS |
$16.78 |
$255,634 |
D/D |
(15,236) |
56,575 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2015-09-21 |
4 |
OE |
$16.78 |
$255,634 |
D/D |
15,236 |
71,811 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2016-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
52,950 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2016-09-20 |
4 |
OE |
$8.00 |
$28,000 |
D/D |
3,500 |
56,450 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2016-09-20 |
4 |
AS |
$8.00 |
$164,075 |
D/D |
(20,500) |
35,950 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
60,975 |
96,925 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2017-06-15 |
4 |
D |
$8.79 |
$13,660 |
D/D |
(1,554) |
95,371 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2017-10-12 |
4 |
OE |
$14.25 |
$570,132 |
D/D |
40,000 |
135,121 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2017-10-12 |
4 |
AS |
$14.25 |
$570,132 |
D/D |
(40,000) |
95,121 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2018-01-02 |
4 |
AS |
$14.72 |
$147,181 |
D/D |
(10,000) |
95,121 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2018-01-02 |
4 |
OE |
$14.72 |
$147,181 |
D/D |
10,000 |
105,121 |
0 |
- |
|
59 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|